Overview: Measles IgM TestIntroduction: The Measles IgM Test detects measles IgM to diagnose recent infection, causing rash or fever. Following 2023 CDC guidelines, it uses immunoassay for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected acute measles infection.
Other Names: Measles IgM Assay, Recent Measles Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Measles IgM testing began in the 1970s with outbreak research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects measles IgM to diagnose recent infection, guides treatment, and evaluates patients with rash or fever.
Test Parameters: 1. Measles IgM Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of rash, fever, or measles exposure.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document rash, fever, cough, or measles exposure. Include current medications, especially antivirals or immunosuppressants.
Consent: Written consent required, detailing the tests purpose, measles infection implications, and risks of blood or saliva collection.
Procedural Considerations: Uses immunoassay to detect measles IgM in serum or saliva. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for acute measles diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Early infection may yield false negatives.
Clinical Significance: Positive measles IgM confirms recent infection, guiding supportive care or isolation measures. Negative results may require PCR testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Measles PCR, IgG test, or throat swab to confirm measles diagnosis.
Test Limitations: Early infection may yield false negatives; clinical correlation is needed. Cross-reactivity with other viruses may occur.
References: CDC Measles Guidelines, 2023; Clinical Infectious Diseases, Griffin DE, 2022.
